This Letter describes size-controlled photocatalytic activity of ZnO nanoparticles coated with glutathione-protected gold nanoparticles with diameters of 1.1, 1.6, and 2.8 nm. The photocatalytic activity of the ZnO–Au composites was found to increase with increasing gold size for both oxidative and reductive catalytic reactions. Photoluminescence decay dynamics of the composites showed that the electron-transfer rate from the photoexcited ZnO to gold nanoparticle also increased as the gold size increased. These results demonstrate that the photogenerated electron transfer and the resulting catalytic activity of the composites can be controlled by the size of the mediating gold capacitors.
Background: The Akt/PKB family of kinases is frequently activated in human cancers, including oral squamous cell carcinoma (OSCC). Akt-induced epithelial-to-mesenchymal transition (EMT) involves downregulation of E-cadherin, which appears to result from upregulation of the transcription repressor Snail. Recently, it was proposed that carcinoma cells, especially in metastatic sites, could acquire the mesenchymal-to-epithelial reverting transition (MErT) in order to adapt the microenvironments and re-expression of E-cadherin be a critical indicator of MErT. However, the precise mechanism and biologic or clinical importance of the MErT in cancers have been little known. This study aimed to investigate whether Akt inhibition would restore the expression of E-cadherin and β-catenin, reduce that of Vimentin, and induce the MErT in OSCC cells with low or negative expression of E-cadherin. We also investigate whether inhibition of Akt activity would affect the E-cadherin repressors and signaling molecules like NF-κB, ERK, and p38.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.